Current state of benefits of Enhanced Recovery After Surgery (ERAS) in spinal surgeries: A systematic review of the literature.


Journal

Neuro-Chirurgie
ISSN: 1773-0619
Titre abrégé: Neurochirurgie
Pays: France
ID NLM: 0401057

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 13 06 2020
revised: 07 03 2021
accepted: 11 04 2021
pubmed: 27 4 2021
medline: 30 12 2021
entrez: 26 4 2021
Statut: ppublish

Résumé

Recent years have been characterized by a great technological and clinical development in spine surgery. In particular, enhanced recovery after surgery (ERAS) programs, started to gain interest also in this surgical field. Here we tried to analyse the current state of art of ERAS technique in spine surgery. A systematic review of the literature has been performed in order to find all the possible inclusions. Using the PRISMA guidelines, a search of the PubMed/Medline, Web of Science, Cochrane Reviews, Embase, Medline databases was conducted to identify all full-text articles in the English-language literature describing the use of ERAS programs or techniques for spine surgery in adult patients. Out of the 827 studies found, only 21 met the inclusion criteria has been retained to be included in the present study. The most frequently benefits of ERAS protocols were shorter hospitalisations (n=15), and decreased complication rates (n=8) lower postoperative pain scores (n=4). These benefits were seen in the 3 main categories considered: lumbar spine surgeries, surgeries for correction of scoliosis or deformity, and surgeries of the cervical spine. There are an arising amount of data showing that the use of ERAS programs could be helpful in reducing the days of hospitalizations and the number of complications for certain spinal procedures and in a highly selected group of patients. Despite the large interest on the topic; there is an important lack of high level of scientific evidences. Because of that, there is the need to encourage the design and creation of new randomized clinical trials that will validate the present findings.

Identifiants

pubmed: 33901525
pii: S0028-3770(21)00107-7
doi: 10.1016/j.neuchi.2021.04.007
pii:
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

61-68

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

I Zaed (I)

Humanitas University, Via Rita Levi Montalcini, Pieve Emanuele (MI), Italy; Department of Neurosurgery, Humanitas Clinical and Research Center, Rozzano (MI), Italy. Electronic address: ismailzaed1@gmail.com.

B Bossi (B)

Humanitas University, Via Rita Levi Montalcini, Pieve Emanuele (MI), Italy.

M Ganau (M)

Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.

B Tinterri (B)

Humanitas University, Via Rita Levi Montalcini, Pieve Emanuele (MI), Italy.

M Giordano (M)

Department of Neurosurgery, International Neuroscience Institute, Hannover, Germany.

S Chibbaro (S)

Department of Neurosurgery, Strasbourg University Hospitals, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH